Showing results (1621-1630 of 7,232) with videos related to

Sort By:
Pageof 724
Genomics|November 1, 1995
The human immediate early gene BRF1 maps to chromosome 14q22-q24K N Maclean, C G See, I A McKay, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 10, 2010
Routine clotting screen has no role in the management of epistaxis: reiterating the pointM Shakeel, A Trinidade, T Iddamalgoda, et al.
BMC Health Services Research|February 21, 2009
Community based yoga classes for type 2 diabetes: an exploratory randomised controlled trialLana Skoro-Kondza, Sharon See Tai, Ramona Gadelrab, et al.
Learning & Memory (Cold Spring Harbor, N.Y.)|December 4, 2008
Chronic cannabinoid administration in vivo compromises extinction of fear memoryHui-Ching Lin, Sheng-Chun Mao, Po-See Chen, et al.
Australian Veterinary Journal|August 14, 2009
Toxicity in three dogs from accidental oral administration of a topical endectocide containing moxidectin and imidaclopridA M See, S E McGill, A L Raisis, et al.
The Journal of Urology|October 27, 2009
MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-GuerinFanghong Chen, Guangjian Zhang, Yanli Cao, et al.
Cancer Research|March 1, 1991
Single-dose preoperative systemic cyclophosphamide for the prevention of bladder tumor implantation in F344 ratsW A See, S A Crist, M A Boileau, et al.
Elife|April 26, 2017
Dual interaction of scaffold protein Tim44 of mitochondrial import motor with channel-forming translocase subunit Tim23See-Yeun Ting, Nicholas L Yan, Brenda A Schilke, et al.
Ear, Nose, & Throat Journal|April 26, 2019
Intracranial Complications of Chronic Otitis Media: Why Does It Still Occur?Hardip Singh Gendeh, Asma Binti Abdullah, Bee See Goh, et al.
European Urology|October 24, 2003
Immediate treatment with bicalutamide 150mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostate cancerW See, P Iversen, M Wirth, et al.
Pageof 724